WELL Living Laboratory in China (WELL-China)
The Stanford WELL for Life Study (WELL) is a unique longitudinal study on wellbeing in the U.S. and globally which collects comprehensive and multidimensional data from participants from the San Francisco Bay Area, China, Taiwan (Tapei and Changua), Singapore, and Thailand. WELL-China is the largest cohort in the study with over 10,000 participants aged between 18 and 80 years, recruited from three districts in the City of Hangzhou, China, between 2016 and 2019. Two levels of follow-up will be carried out starting in late autumn 2020: the biennial active follow-up of the entire cohort and the biannual follow-up of a nested-omics cohort of 250–500 participants.
Study design
Cohort, Biobank
Number of participants at first data collection
10,268 (participants)
Age at first data collection
≥ 18 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
2016
Primary Institutions
Stanford University (Academic, United States of America)
Zhejiang University (浙江大学, ZJU) (Academic, China)
Profile paper DOI
Funders
Amway (Industry, United States of America)
Cyrus Tang Foundation (Third Sector, United States of America)
Stanford Department of Medicine (Academic, United States of America)
Zhejiang University Education Foundation (Third Sector, China)
Ongoing?
Yes
Data types collected
- Activity log (e.g. food, sleep, exercise)
- Interview – face-to-face
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- Interviews or focus groups
- None
- None
Engagement
Keywords
Consortia and dataset groups
